ANI Pharmaceuticals, Inc. (ANIP)
70.34
-1.12
(-1.57%)
USD |
NASDAQ |
Sep 11, 12:53
ANI Pharmaceuticals Gross Profit (TTM) : 505.18M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 505.18M |
| March 31, 2026 | 472.41M |
| December 31, 2025 | 450.64M |
| September 30, 2025 | 414.16M |
| June 30, 2025 | 371.87M |
| March 31, 2025 | 324.04M |
| December 31, 2024 | 296.44M |
| September 30, 2024 | 271.78M |
| June 30, 2024 | 270.79M |
| March 31, 2024 | 264.72M |
| December 31, 2023 | 245.51M |
| September 30, 2023 | 225.89M |
| June 30, 2023 | 194.13M |
| March 31, 2023 | 159.36M |
| December 31, 2022 | 120.63M |
| September 30, 2022 | 90.55M |
| June 30, 2022 | 70.10M |
| March 31, 2022 | 60.28M |
| December 31, 2021 | 68.27M |
| September 30, 2021 | 76.74M |
| June 30, 2021 | 81.94M |
| March 31, 2021 | 83.53M |
| December 31, 2020 | 76.68M |
| September 30, 2020 | 80.07M |
| June 30, 2020 | 85.43M |
| Date | Value |
|---|---|
| March 31, 2020 | 98.11M |
| December 31, 2019 | 103.38M |
| September 30, 2019 | 106.48M |
| June 30, 2019 | 106.16M |
| March 31, 2019 | 99.27M |
| December 31, 2018 | 94.81M |
| September 30, 2018 | 86.32M |
| June 30, 2018 | 79.76M |
| March 31, 2018 | 73.94M |
| December 31, 2017 | 69.88M |
| September 30, 2017 | 65.55M |
| June 30, 2017 | 61.45M |
| March 31, 2017 | 58.50M |
| December 31, 2016 | 57.50M |
| September 30, 2016 | 54.40M |
| June 30, 2016 | 53.17M |
| March 31, 2016 | 54.54M |
| December 31, 2015 | 56.73M |
| September 30, 2015 | 60.43M |
| June 30, 2015 | 58.90M |
| March 31, 2015 | 47.77M |
| December 31, 2014 | 40.62M |
| September 30, 2014 | 31.72M |
| June 30, 2014 | 21.68M |
| March 31, 2014 | 16.05M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Viatris, Inc. | 5.838B |
| Liquidia Corp. | 416.18M |
| Elanco Animal Health, Inc. | 2.223B |
| Harmony Biosciences Holdings, Inc. | 700.15M |
| Corcept Therapeutics, Inc. | 816.73M |